Nomifensine

CAS No. 24526-64-5

Nomifensine( (±)-Nomifensin | NOMIFENSINE MALEATE )

Catalog No. M20731 CAS No. 24526-64-5

Nomifensine is a norepinephrine-dopamine reuptake inhibitor that prevents dopamine reuptake into synaptosomes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 29 In Stock
25MG 43 In Stock
50MG 60 In Stock
100MG 99 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nomifensine
  • Note
    Research use only, not for human use.
  • Brief Description
    Nomifensine is a norepinephrine-dopamine reuptake inhibitor that prevents dopamine reuptake into synaptosomes.
  • Description
    Nomifensine is a norepinephrine-dopamine reuptake inhibitor that prevents dopamine reuptake into synaptosomes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (±)-Nomifensin | NOMIFENSINE MALEATE
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    dopamine reuptake
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24526-64-5
  • Formula Weight
    238.33
  • Molecular Formula
    C16H18N2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:300 mg/mL (1258.76 mM)
  • SMILES
    CN1CC(c2ccccc2)c2cccc(N)c2C1
  • Chemical Name
    8-Isoquinolinamine 1234-tetrahydro-2-methyl-4-phenyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hoffmann I . Pharmacology of Nomifensine[J]. International Pharmacopsychiatry 1982 17(S1):4-20.
molnova catalog
related products
  • WAY-260022

    WAY-260022 is an orally available and selective norepinephrine transporter protein inhibitor that displays inhibitory effects on serotonin and dopamine transporter proteins.

  • OS-3-106

    OS-3-106 ?is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.

  • ONC206

    ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??